<DOC>
	<DOCNO>NCT02240589</DOCNO>
	<brief_summary>The purpose study determine memantine improve cognitive neuropsychiatric outcome severe traumatic brain injury .</brief_summary>
	<brief_title>Memantine Neuroprotection Cognitive Enhancement Following Traumatic Brain Injury</brief_title>
	<detailed_description>This pilot/feasibility study memantine severe traumatic brain injury ( TBI ) person , employ randomize , double-blind , placebo-controlled , design . Outcome evaluation occur 24 week treatment ( medication ) 4 week treatment discontinuation .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Brain Injuries</mesh_term>
	<mesh_term>Memantine</mesh_term>
	<criteria>1865 year old age time enrollment Severe traumatic brain injury ( TBI ) Feeding access ( e.g. , orogastric ( OG ) , nasogastric ( NG ) , percutaneous endoscopic gastrostomy ( PEG ) tube ) permit delivery memantine placebo Availability legallyauthorized representative ( LAR ) provide consent participate study activity ( e.g. , monitor side effect , provide information patient ) Preexisting history serious neurological disorder Preexisting history serious psychiatric disorder ( e.g. , schizophrenia ) Anticipated poor prognosis , base presence bilaterally fix dilate pupil , severe hemodynamic instability , severe elevation intracranial pressure refractory intervention , factor lead determination probable nonsurvivable injury Primarily penetrate mechanism injury ( e.g. , gunshot wound head ) Isolated epidural hematoma anticipate good prognosis Low probability participant compliant able finish study procedure ( e.g. , present outcome rating ) judgment investigator Not English speaking ( due inability complete outcome measure ) Medical contraindication memantine : Severe hepatic impairment ( define albumin &gt; 15gm/dL , Alk Phos &gt; 375 U/L , ALT &gt; 150 U/L , AST &gt; 120 U/L bilirubin &gt; 3mg/dL ) . ModeratetoSevere renal impairment ( defined creatinine clearance &lt; 60 ) Pregnancy breastfeed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Traumatic Brain Injury</keyword>
	<keyword>Memantine</keyword>
	<keyword>Memory</keyword>
</DOC>